OSIMPLANT DIVISION ESPAÑA SL
Company details
- Active NIF/CIF: B57897449
-
-
-
-
Address: C/ GABRIEL MAURA 20 1 A (PALMA DE MALLORCA)
-
-
Featured products:
More information on OSIMPLANT DIVISION ESPAÑA SL
-
17/03/2022 | BORME act no.: 117368 | Register: ILLES BALEARSModificaciones estatutarias
-
05/03/2018 | BORME act no.: 103204 | Register: ILLES BALEARSCambio de denominación social
-
19/12/2016 | BORME act no.: 510402 | Register: ILLES BALEARSDeclaración de unipersonalidad
-
01/12/2015 | BORME act no.: 485334 | Register: ILLES BALEARSCeses/Dimisiones
-
01/12/2015 | BORME act no.: 485334 | Register: ILLES BALEARSNombramientos
-
20/04/2015 | BORME act no.: 160238 | Register: ILLES BALEARSConstitución
-
20/04/2015 | BORME act no.: 160238 | Register: ILLES BALEARSNombramientos
Other information
The CIF assigned to OSIMPLANT DIVISION ESPAÑA SL is B57897449, and its commercial status is active. The company carries out its operations within the CNAE 8690 - Other health activities. Likewise, its SIC code 8099 - Servicios sanitarios y similares identifies it.
OSIMPLANT DIVISION ESPAÑA SL employs a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Illes balears and has 3 registration charges. The last announcement in Borme was published on 17/03/2022, while the most recent deposit of ordinary annual accounts is from the year 2022.
To access the contact information of OSIMPLANT DIVISION ESPAÑA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about OSIMPLANT DIVISION ESPAÑA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about OSIMPLANT DIVISION ESPAÑA SL comes from official sources and is regularly updated.
Do you want to know more about OSIMPLANT DIVISION ESPAÑA SL??
Find out more about this company by consulting these reports: